Ellis Investment Partners’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-912
| Closed | -$67K | – | 418 |
|
|
2022
Q3 | $67K | Hold |
912
| – | – | 0.02% | 350 |
|
|
2022
Q2 | $59K | Hold |
912
| – | – | 0.02% | 382 |
|
|
2022
Q1 | $57K | Hold |
912
| – | – | 0.01% | 400 |
|
|
2021
Q4 | $48K | Hold |
912
| – | – | 0.01% | 430 |
|
|
2021
Q3 | $64K | Hold |
912
| – | – | 0.02% | 368 |
|
|
2021
Q2 | $60K | Hold |
912
| – | – | 0.02% | 376 |
|
|
2021
Q1 | $101K | Hold |
912
| – | – | 0.03% | 292 |
|
|
2020
Q4 | $108K | Hold |
912
| – | – | 0.03% | 275 |
|
|
2020
Q3 | $79K | Hold |
912
| – | – | 0.03% | 290 |
|
|
2020
Q2 | $81K | Hold |
912
| – | – | 0.03% | 281 |
|
|
2020
Q1 | $83K | Hold |
912
| – | – | 0.04% | 220 |
|
|
2019
Q4 | $105K | Hold |
912
| – | – | 0.04% | 226 |
|
|
2019
Q3 | $113K | Hold |
912
| – | – | 0.04% | 211 |
|
|
2019
Q2 | $109K | Buy |
+912
| New | +$109K | 0.04% | 214 |
|